Price $4.80 |
Market Cap
163.4M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
1.91
|
P/S
-
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-48K
|
FCF
-1.8
|
|
Op. Margin
-
|
Net Margin
-
|
ROE
-71.80%
|
ROI
-
|
|
ROA
-65.10%
|
EPS Growth
-31.50%
|
Current Ratio
4.6
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| MGC Diagnostics Corp (MGCD) | $7.86 | - | - | 35.1M | Strong Buy |
| Aytu Bioscience Inc (AYTU) | $0.21 | - | - | 6.7M | Strong Buy |
| Alere Inc (ALR) | $49.55 | - | - | 4.41B | Strong Buy |
| Biostar Pharmaceuticals Inc (BSPM) | $1.32 | - | - | 3.9M | Strong Buy |
| Navidea Biopharmaceuticals Inc (NAVB) | $0.41 | - | - | 68M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
